EPO Patent Grant: Method for obtaining improved fitness sperm cells

The European Patent Office has granted patent EP3752597B1 for a method to obtain a sperm cell population with improved fitness. The patent is effective March 18, 2026, and covers various designated states within the European Union.

EPO Patent EP3699284B1: U1 Snrnp Regulates Gene Expression

The European Patent Office has granted patent EP3699284B1, titled 'U1 Snrnp Regulates Gene Expression and Modulates Oncogenicity'. This patent relates to specific gene regulation mechanisms and their potential impact on oncogenicity, with implications for biotechnology and pharmaceutical research.

EPO Patent Grant EP3735459B1: DNA-Based Digital Information Storage

The European Patent Office has granted patent EP3735459B1 for DNA-based digital information storage. The patent, listing Brian Wayne Bramlett and Bill James Peck as inventors, was published on March 18, 2026. This grant pertains to novel methods and systems for utilizing DNA for data storage.

EPO Grants Gene Therapy Patent EP3752608B1

The European Patent Office (EPO) has granted patent EP3752608B1 for a gene therapy related to the FAAH pseudogene. The patent was officially granted on March 18, 2026, and covers various European states.

EPO Patent Grant EP3707250B1: SO3 Chromatography for Virus Purification

The European Patent Office has granted patent EP3707250B1 for a method of virus purification using SO3 chromatography. This patent is designated for use in multiple European states and relates to advancements in biotechnology for pharmaceutical applications.

EPO Patent EP3612195B1: Stimulating Satellite Stem Cell Division

The European Patent Office has granted patent EP3612195B1 for a method of stimulating asymmetric division of satellite stem cells. This patent, effective March 18, 2026, covers specific applications in biotechnology and regenerative medicine.

Hydrogel Patent for Cell Culture and Biomedical Applications

The European Patent Office has granted patent EP3609956B1 for a hydrogel intended for cell culture and biomedical applications. The patent lists Hongzhou Huang as the inventor and covers various International Patent Classifications related to biomaterials and cell culture.

EPO Patent EP3688142B1: Isolating T Cells for P53 Cancer Mutation

The European Patent Office has granted patent EP3688142B1, titled 'Methods of Isolating T Cells Having Antigenic Specificity for a P53 Cancer-Specific Mutation'. This patent relates to methods for isolating T cells for cancer treatment and is designated for multiple European states.

EPO Patent Grant: Additive for Undifferentiation Maintaining Medium

The European Patent Office (EPO) has granted patent EP3604503B1 for an additive used in a medium for maintaining undifferentiation. The patent was granted on March 18, 2026, and applies to several European member states.

EPO Patent Grant EP3609527B1 for Protein Conjugates

The European Patent Office (EPO) has published patent grant EP3609527B1 concerning protein conjugates. This grant, effective March 18, 2026, covers specific inventions related to protein conjugate technology.